Prospective Description of Coughing, Hemodynamic Changes, and Oxygen Desaturation During Endoscopic Sedation
- 278 Downloads
Deep sedation is increasingly used for endoscopy. The impact of sedation level on hemodynamic status, oxygenation, and aspiration risk is incompletely described.
To describe the incidence of intraprocedural cough, hemodynamic changes, oxygen desaturation, and their relationship to clinical factors and sedation level.
Detailed prospective recordings of hemodynamic changes, oxygen desaturation, and cough during 757 nonemergent endoscopic procedures done under sedation using propofol, midazolam, and/or fentanyl.
Thirteen percent of patients had at least one cough and 3% had prolonged cough. Cough was more common in nonsmokers (P = 0.05), upper endoscopy (P < 0.0001), with propofol (P = 0.0008), longer procedures (P = 0.0001), and hiccups (P = 0.01). The association between supine positioning during colonoscopy and cough approached significance (P = 0.06). Oxygen desaturation was rare (4%) and associated only with deep sedation (P = 0.02). Mean systolic and diastolic blood pressure (BP) dropped by 7.3 and 5.6% respectively. Decreases in systolic BP were more common in whites (P = 0.03), males (P = 0.004), nonsmokers (P = 0.04), during colonoscopy (P < 0.0001), and in patients receiving midazolam and fentanyl (P = 0.01). Heart rate (HR) dropped >20% from baseline in 15% of patients and was more common during colonoscopy (P = 0.002). HR increased >20% in 20% of patients and was more common with coughing (P < 0.0001) and in younger patients (P = 0.0002). No patient required pharmacologic treatment of BP or HR.
We have described procedural predictors of cough that may help clinicians reduce the risk of aspiration during endoscopy. Hemodynamic changes during endoscopy are common but largely clinically insignificant.
KeywordsEndoscopy, digestive system/adverse effects Deep sedation/adverse effects Propofol/adverse effects Hemodynamics Cough Oxygen saturation
- 1.Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc. 1991;37:421–427.PubMedCrossRefGoogle Scholar
- 8.Rex DK, Deenadayalu VP, Eid E, et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology. 2009;137:1229–1237; quiz 1518–1229.Google Scholar
- 23.Cote GA, Hovis RM, Ansstas MA, et al. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures. Clin Gastroenterol Hepatol. 2010;8:137–142.Google Scholar
- 29.Paspatis GA, Charoniti I, Manolaraki M, Vardas E, et al. Synergistic sedation with oral midazolam as a premedication and intravenous propofol versus intravenous propofol alone in upper gastrointestinal endoscopies in children: a prospective, randomized study. J Pediatr Gastroenterol Nutr. 2006;43:195–199.PubMedCrossRefGoogle Scholar
- 34.Ciriza de los Rios C, Fernandez Eroles AL, Garcia Menendez L, et al. Sedation in upper gastrointestinal endoscopy. Analysis of tolerance, complications and cost-effectiveness. Gastroenterol Hepatol. 2005;28:2–9.Google Scholar
- 45.Statement on Granting Privileges to Non Anesthesiologist Practitioners for Personally Administering Deep Sedation or Supervising Deep Sedation by Individuals who are not Anesthesia Professionals. Available at: http://www.asahq.org/publicationsAndServices/~/media/ForMembers/documents/StandardsGuidelinesStmts/GrantingPrivilegestoNonAnesthesiologistPractitionersforPersonallyAdministeringDeepSedation.ashx. Accessed February 17, 2011.
- 46.Revised Hospital Anesthesia Services Interpretive Guidelines—State Operations Manual (SOM) AppendixA. Available at: www.cms.gov/SurveyCertificationGenInfo/downloads/SCLetter10_09.pdf. Accessed January 27, 2011.